Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HYTN Innovations Inc C.HYTN

Energy Oil & Gas E&P
HYTN Innovations Inc. is a Canada-based company that creates products containing psychoactive and psychotropic compounds, including cannabinoids derived from cannabis. The Company formulates, manufactures, markets, and sells cannabis goods. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. All its sparkling cannabis beverages contain... see more

Recent & Breaking News (CSE:HYTN)

HYTN Innovates GMP Stability Programs, Sets Industry Benchmark

GlobeNewswire 4 days ago

HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities

GlobeNewswire April 9, 2024

HYTN Provides Corporate Update, Outlines New Global Direction

GlobeNewswire April 3, 2024

HYTN Secures GMP Certification

GlobeNewswire March 21, 2024

HYTN Clears PIC/S GMP Audit, Primed for Global Expansion

GlobeNewswire March 4, 2024

HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot

GlobeNewswire February 20, 2024

HYTN Announces Non-Brokered Private Placement for up to C$1 Million

GlobeNewswire February 9, 2024

HYTN Announces Closing of Non-Brokered Private Placement Under Listed Issuer Financing Exemption

GlobeNewswire October 26, 2023

HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine

GlobeNewswire March 2, 2023

HYTN (CSE:HYTN) begins cultivating psilocybin mushrooms

John Ballem  February 23, 2023

HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development

GlobeNewswire February 23, 2023

HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio and Increases Sales of Rapid Onset Cannabis Products Using Proprietary Elevation Technology

GlobeNewswire February 16, 2023

HYTN (CSE:HYTN) sells out of innovative holiday products

Shoran Devi November 30, 2022

HYTN Sells Out of Innovative Holiday Products

GlobeNewswire November 30, 2022

HYTN (CSE:HYTN) signs agreement with Rose to initiate sales of cannabis products in Quebec

Shoran Devi October 24, 2022

HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose

GlobeNewswire October 24, 2022

HYTN (CSE:HYTN) awarded controlled drugs & substances dealer’s license

Jonathon Brown October 17, 2022

HYTN Awarded Controlled Drugs and Substances Dealer's License Allowing for Production and Sale of Psilocybin

GlobeNewswire October 17, 2022

HYTN (CSE:HYTN) opens provincial and territorial markets for Tricanna manufactured pre-rolled cannabis products

Shoran Devi September 29, 2022

HYTN Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products

GlobeNewswire September 29, 2022